<DOC>
	<DOCNO>NCT01036321</DOCNO>
	<brief_summary>The purpose study recruit treat 96 men diagnose prostate cancer schedule prostatectomy capsule form either purified isoflavones placebo 3-6 week period see slow rate prostate cancer growth . A placebo pill something look like medicine study active medicine . We also want see take purified isoflavones safe reduces low urinary tract symptom . In addition , want study purify isoflavones able slow progression prostate cancer , mechanism action purify isoflavones . If safety effect purify isoflavones slow progression prostate cancer show study , also safe way treat men high risk prostate cancer , prevent prostate cancer future .</brief_summary>
	<brief_title>Phase II Clinical Trial Purified Isoflavones Prostate Cancer : Comparing Safety , Effectiveness</brief_title>
	<detailed_description>Patients need take two ( 2 ) capsule daily , one breakfast one dinner . On day prior day patient come pre-operative surgery blood work , ask take second dose lunch , appointment afternoon . At start study end study ( 3-6 week ) , patient undergo interview , complete questionnaire , lab test determine drug effective reduce progression prostate cancer safe use . Patients also receive multivitamin/mineral supplement 3-6 week study require take one ( 1 ) every day . It require patient take vitamin/mineral herbal preparation contain isoflavones avoid eat drink soy product . We anticipate patient schedule prostatectomy 3-6 week ( +/- 3 day ) start study agent . In addition first visit , patient require come day surgery prostatectomy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Diagnosis localize prostate cancer ( PCa ) , base pathological assessment biopsy specimens No prior current therapy PCa history cancer except nonmelanoma skin cancer Scheduled prostatectomy 3 6 week ( +/3 day ) start study agent No known history hepatic renal disease ( LFTs ( SGOT/SGPT ) &gt; 5.0 x upper limit normal evidence impairment baseline laboratory value , Actual creatinine clearance &gt; 60 utilizing CockcroftGault formula ( 1976 ) , employ creatinine measurement patient 's weight predict clearance . The constant 1.23 men . Omnivorous diet No evidence prostatitis urinary tract infection Able willing give write informed consent Currently use willing discontinue nutritional supplement contain soy soy isoflavones Not allergic study supplement Not antibiotic Men consume 3 4 oz . soy soy product per week Not take steroid hormone medication know impact prostatic specific antigen ( PSA ) Health status clear primary MD urologist Eastern Cooperative Oncology Group ( ECOG ) performance status 01 Prior history prostate cancer ; Current prior history malignancy ( exception include nonmelanoma skin cancer cancer evidence tumor recurrence five year definitive treatment ) History renal hepatic disease , include history hepatitis B , C delta evidence impairment baseline laboratory value Participation investigational study use investigational agent within 30 day study entry History allergic reaction attribute soy isoflavones compound similar chemical biologic composition Novasoy 400Â® inactive component present purify isoflavone placebo capsule Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychological , familial , sociological concomitant condition would allow adequate compliance study protocol Only African American ( person origins black racial group Africa ) Caucasian ( person origins original people Europe , Middle East , North Africa ) men , define NIH , include study . Since investigation target men PCa , woman eligible study .</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>